Round table to explore how different forms of DNA can be translated into precision diagnostics and clinical decision-making. The session will bring together projects and stakeholders across the diagnostic pathway: from early-stage in academia, through investors and regulators, to the pharmaceutical industry. The goal is to connect science, clinical utility, health-system access, commercialization and investment in one practical conversation.
Presentation
Session Overview
Precision diagnostics are reshaping modern medicine, but turning breakthrough research into standard clinical practice involves navigating complex regulatory, economic, and healthcare systems. This session connects science, clinical utility, health-system access, commercialization, and investment in one practical, cross-disciplinary conversation.
By gathering perspectives from early-stage academic researchers, investors, regulatory experts, and the pharmaceutical industry, this session provides a comprehensive look at what it takes to overcome translational hurdles and deliver precision diagnostics to patients.
Key Discussion Points
- Demonstrating Clinical Utility: Moving from biomarker identification to proving concrete value in patient outcomes and clinical workflows.
- Navigating Regulatory & Health-System Access: Strategies for addressing regulatory pathways, reimbursement strategies, and adoption within health systems.
- Commercialization & Investment: Bridging the gap between early-stage academic concepts and investor requirements to successfully scale technologies.
Why Attend?
Whether you are a researcher developing a diagnostic tool, a clinician seeking actionable biomarkers, an investor evaluating life science technologies, or an industry leader exploring strategic partnerships, this session offers:
End-to-End Insights: A 360-degree view of the diagnostic pathway from basic research to market access.
- Practical Guidance: Real-world strategies for tackling regulatory, reimbursement, and commercialization challenges.
- Cross-Sector Networking: A unique platform to connect with key stakeholders across academia, investment, regulation, and pharma.
Join us to bridge the gap between genomic discovery and clinical application, and help shape the future of precision medicine.
Date & Place
10:00- 11:30 h: Tuesday, 16 February 2027 - Sala Dolors Aleu, Parc Científic de Barcelona.
This event takes place during the Barcelona Health Innovation Week 2027 promoted by Biocat - #BCNHealthInnovationWeek.
Registration
Free and open to the whole Life-Science community. Registration required before Friday, 5 February(REGISTRATION LINK)
Held within the
